Why 40 Is the Tipping Point
By 40, the average man has lost 10-20% of his peak testosterone. For most, this decline has been gradual enough to go unnoticed. But the 40s are when the cumulative deficit starts to create unmistakable symptoms. Energy that sustained you through your 30s is no longer reliable. The body composition changes become impossible to ignore. Recovery from both exercise and illness takes noticeably longer. And the mental edge that defined your professional peak begins to dull.
This is also the decade when cardiovascular risk, metabolic syndrome, and bone density loss begin to accelerate. Testosterone is protective against all three. Its decline is not just a quality of life issue. It is a health risk multiplier.
Who Actually Qualifies
TRT is a medical treatment for diagnosed testosterone deficiency, not a performance enhancement. You qualify when lab work confirms low testosterone, typically below 300 ng/dL on two separate morning tests, combined with symptoms consistent with deficiency. Some providers use a functional threshold of 350-400 ng/dL when symptoms are pronounced and other causes have been ruled out.
Conditions that may disqualify or delay treatment include active prostate cancer, severe untreated sleep apnea, uncontrolled heart failure, polycythemia with hematocrit above 54%, and desire for near-term fertility without adjunctive therapy.
Benefits Backed by Evidence
The TRAVERSE trial, the largest and longest testosterone safety study ever conducted with over 5,000 men, confirmed that TRT does not increase cardiovascular risk and demonstrated meaningful improvements across multiple domains. Patients experienced improved sexual function including libido and erectile quality, increased lean body mass and decreased fat mass, improved bone mineral density, better mood and reduced depressive symptoms, and improved energy and physical function.
These benefits are dose-dependent and time-dependent. Most men notice energy and mood improvements within two to four weeks, sexual function improvement within four to eight weeks, and body composition changes within three to six months.
Risks and Monitoring
TRT is not risk-free. The most common side effects include erythrocytosis where hematocrit rises above normal levels requiring monitoring and potential dose adjustment, acne particularly in the first few months, testicular atrophy from suppressed gonadotropins which is manageable with HCG if desired, and estradiol elevation from aromatization which can cause water retention or mood changes if unmanaged.
Regular monitoring every three to six months tracks hematocrit, PSA, estradiol, and liver function to catch and address issues early. With proper monitoring, the risk profile of TRT is well-characterized and manageable.
What Treatment Looks Like
The most common TRT protocol for men over 40 is testosterone cypionate injected subcutaneously or intramuscularly once or twice weekly. Starting doses are typically 100-120 mg per week, adjusted based on lab results and symptom response at six to eight week intervals. Some men prefer daily topical gels or creams, which provide more stable levels but require daily application and carry transfer risk to partners and children.
The target is mid-normal testosterone levels of 500-800 ng/dL, not supraphysiological levels. The goal is to restore what your body should be producing, not to exceed natural limits.
Getting Started
The path to TRT starts with comprehensive lab work. A panel measuring total and free testosterone, SHBG, estradiol, LH, FSH, PSA, CBC, and metabolic markers establishes your baseline and rules out secondary causes of low testosterone. This can be done through an at-home lab kit or a local draw. Results are reviewed by a licensed provider who determines eligibility and designs your protocol.